Living a better life with type 1 diabetes

Navn
Julie Roland Sørensen
Uddannelsesgrad
Kandidat
Fagfelt
Design
År
2018
Udmærkelser
KADK's FN-pris

This thesis explores the process of designing electronic self-treatment medical products that are used in the everyday life of adolescents people with type 1 diabetes.

The result of this project is a modular family of self-treatment medical electronic devices designed for type 1 diabetes patients. The family consists of one blood glucose monitor device and one insulin pump device, which are modularly attached to patches that are then fastened on the users body. The patches can be placed everywhere on the body and comes in 3 types of patch materials, that fit different skin types. The blood glucose monitor measure the body’s blood glucose level with sensor technology, and the insulin pump gives the user insulin trough a small plastic pipe that is inserted into the body. The two devices communicate wirelessly and the blood glucose monitor informs the insulin pump whenever the body needs insulin. Both devices are made of flexible materials and technology adapting to the movement of the body. The cover of the devices can be changed so the user can customize the color of the two products to their individual preferences.

 

 

6 billeder

How to use the products

6 billeder

Colors

6 billeder

Technical details

6 billeder

Det Kongelige Akademi understøtter FN’s verdensmål

Siden 2017 har Det Kongelige Akademi arbejdet med FN’s verdensmål. Det afspejler sig i forskning, undervisning og afgangsprojekter. Dette projekt har forholdt sig til følgende FN-mål
PRIS

KADK's FN-pris

Julie Roland modtog KADK's FN-pris for sit afgangsprojekt. Juryen sagde bl.a.: 
'Julie formår på højeste niveau, gennem research  og analyser at programmere og udvikle et designprojekt. I afgangsprojektet gives der et designforslag på spørgsmålet: Hvordan kan design forbedre liv og velvære for patienter med type 1 diabetes? ... Gennem utallige materiale- og funktionsmodeller er designet blevet afprøvet på og diskuteret med brugere for at opnå en løsning, der også i den virkelige verden løser mange af de problemer diabetes 1 patienter har pga. deres sygdom.'